InSphero Secures Exclusive Commercialization Partnership with Genome Biologics for 3D Cardiac Organoid Platform
InSphero AG is pleased to announce its exclusive commercialization of TrueCardium® Cardiac Organoid Platform in partnership with Genome Biologics. SCHLIEREN, ZURICH, SWITZERLAND, May 16, 2024 /EINPresswire.com/ -- In a significant expansion of its …